EX-99.1 6 a07-11073_1ex99d1.htm EX-99.1

Exhibit 99.1

XELR8 HOLDINGS ACHIEVES RECORD SALES IN FIRST QUARTER 2007

Tele-Conference and WebCast Scheduled for this Afternoon Beginning at 4:15 PM ET

DENVER, Colo. (PR NEWSWIRE) April 30, 2007 – XELR8 Holdings, Inc. (AMEX:BZI), a provider of functional foods, beverages and nutritional supplements, today announced results for the three months ended March 31, 2007.

Financial and Operational Highlights for Three Months Ended March 31, 2007 Compared to Three Months Ended March 31, 2006

·                  Net cash used by operations fell 84% to $177,000 from $1.13 million.

·                  Revenues of $870,000 were up 61% over $539,000, and represented record sales for a single quarter.

·                  Gross profit margin on sales rose to 65% from 55%.

·                  Net loss totaled $1.36 million, or $0.13 per basic and diluted common share, a 12% decline from a net loss of $1.55 million, or $0.16 per basic and diluted common shares.

·                  As of March 31, 2007, the Company had approximately $1.46 million in cash, $2.01 million in total current assets, no long term debt, $1.26 million in working capital, and total shareholders’ equity of $1.39 million

·                  The total number of program participants in XELR8’s direct selling network as of the end of March exceeded 4,000, with nearly 700 joining in the month of March alone.

·                  Bazi, the Company’s new nutritional liquid dietary supplement introduced to market in mid-January of this year, represented 68% of total sales posted for the first quarter.

·                  At its annual meeting of shareholders held in early March 2007, stockholders approved the corporate name change from VitaCube Systems Holdings, Inc. to XELR8 Holdings, Inc., and on March 20, the Company initiated trading on the American Stock Exchange under its new ticker symbol, “BZI”.

John Pougnet, CEO and CFO of XELR8, stated, “When reflecting on the first quarter results, we’re perhaps most pleased with the significant improvement we saw in the net cash used by operations.  The growth of our Company has been truly outstanding over the past several months.  As more distributors and customers have joined the XELR8 team, thanks largely to the early success of Bazi, we have accelerated our drive towards achieving positive cash flow and profitability, and now have real visibility into achieving these critical milestones in the quarters ahead, presuming these positive growth trends persist.”

XELR8 will host a teleconference this afternoon beginning at 4:15 PM Eastern Time, and invites all interested parties to join management in a discussion regarding the Company’s financial results, corporate progression and other meaningful developments.  The conference call can be accessed via telephone by dialing toll free 800-240-2430, or via the Internet at www.xelr8.com.   For those unable to participate at that time, a replay of the webcast will be available for 90 days on www.xelr8.com.  

About XELR8 Holdings, Inc.

XELR8 Holdings, Inc. is a provider of nutritional foods and beverages designed to help enhance physical health and overall performance.  XELR8 has developed a comprehensive line of nutritional supplements and functional foods designed in systems that are easy to take, simple to understand, and conveniently fit within a lifestyle. These include the Company’s Eat/Drink/Snack System; Peak Performance System; and its newest market entry, Bazi, a powerful, concentrated, antioxidant nutritional drink packed with eight different superfruits and berries, including the Chinese jujube plus 12 vitamins and 68 minerals, providing all the daily vitamin and minerals you need in a single, convenient, one-ounce shot.

XELR8’s commitment to quality, science and research has earned the Company a loyal following of over 350 world-class athletes and an elite list of endorsers, such as five-time Cy Young Award Winner Randy Johnson; Super Bowl Champions Mike Alstott, Lawyer Milloy and Head Coach Mike Shanahan; professional football superstar Cadillac Williams; Olympians Briana Scurry and Caroline Lalive; Stanley Cup Winner Blake Sloan; and PGA Tour Professional Tom Pernice, Jr.  XELR8 products




are only available through independent distributors located throughout the nation.  For more information about XELR8, please visit www.xelr8.com or www.drinkbazi.com.

XELR8 HOLDINGS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)

 

 

March 31, 2007

 

December 31, 2006

 

 

 

 

 

 

 

ASSETS

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

 

1,456,032

 

$

76,147

 

Accounts receivable, net of allowance for doubtful accounts of $13,074 and $10,706, respectively

 

6,469

 

4,785

 

Inventory, net of allowance for obsolescence of $123,105 and $41,655, respectively

 

370,402

 

411,364

 

Prepaid expenses and other current assets

 

179,781

 

259,292

 

Total current assets

 

2,012,684

 

751,588

 

 

 

 

 

 

 

Intangible assets, net

 

10,936

 

11,212

 

Property and equipment, net

 

112,440

 

123,943

 

Deferred offering and loan costs

 

 

133,889

 

 

 

 

 

 

 

Total assets

 

$

2,136,060

 

$

1,020,632

 

 

 

 

 

 

 

LIABILITIES AND SHAREHOLDERS’ EQUITY (DEFICIT)

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Accounts payable and accrued expenses

 

$

749,137

 

$

1,160,916

 

Bridge loan financing

 

 

250,000

 

 

 

 

 

 

 

Total liabilities

 

749,137

 

1,410,916

 

 

 

 

 

 

 

Commitments and Contingency

 

 

 

 

 

 

 

 

 

 

 

SHAREHOLDERS’ EQUITY (DEFICIT):

 

 

 

 

 

Preferred stock, authorized 5,000,000 shares, $.001 par value, none issued or outstanding

 

 

 

Common stock, authorized 50,000,000 shares, $.001 par value, 14,197,170 and 10,097,170 issued and outstanding respectively

 

14,197

 

10,097

 

Additional paid in capital

 

19,987,116

 

16,849,900

 

Accumulated (deficit)

 

(18,614,390

)

(17,250,281

)

 

 

 

 

 

 

Total shareholders’ equity (deficit)

 

1,386,923

 

(390,284

)

 

 

 

 

 

 

Total liabilities and shareholders’ equity (deficit)

 

$

2,136,060

 

$

1,020,632

 

 




XELR8 HOLDINGS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

Three Months Ended March 31, 2007 and 2006

 

 

2007

 

2006

 

 

 

 

 

 

 

Net sales

 

$

869,075

 

$

538,960

 

Cost of goods sold

 

305,593

 

245,379

 

Gross profit

 

563,482

 

293,581

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

Selling and marketing expenses

 

629,266

 

1,025,138

 

General and administrative expenses

 

849,521

 

803,813

 

Research and development expenses

 

614

 

24,570

 

Depreciation and amortization

 

11,779

 

7,650

 

Total operating expenses

 

1,491,180

 

1,861,171

 

 

 

 

 

 

 

Net (loss) from operations

 

(927,698

)

(1,567,590

)

Other income (expense)

 

 

 

 

 

Interest income

 

3,126

 

18,268

 

Interest (expense)

 

(439,537

)

 

 

 

 

 

 

 

Total other income (expense)

 

(436,411

)

18,268

 

 

 

 

 

 

 

Net (loss)

 

$

(1,364,109

)

$

(1,549,322

)

 

 

 

 

 

 

Net (loss) per common share

 

 

 

 

 

Basic and diluted net (loss) per share

 

$

(0.13

)

$

(0.16

)

 

 

 

 

 

 

Weighted average common shares outstanding, basic and diluted

 

10,753,350

 

9,620,898

 

 




XELR8 HOLDINGS, INC. CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

Three Months Ended March 31, 2007 and 2006

 

 

2007

 

2006

 

Cash flows from operating activities:

 

 

 

 

 

Net Income (Loss)

 

$

(1,364,109

)

$

(1,549,322

)

Adjustments to reconcile

 

 

 

 

 

Depreciation and amortization

 

11,779

 

7,650

 

Stock and stock options issued for services

 

474,912

 

179,869

 

Interest expense and amortization related to bridge loan financing

 

428,889

 

 

Change in allowance for doubtful accounts

 

2,368

 

1,036

 

Change in allowance for inventory obsolescence

 

81,450

 

57,594

 

Change in allowance for product returns

 

30,866

 

4,158

 

Changes in assets and liabilities:

 

 

 

 

 

Accounts receivable

 

(4,052

)

710

 

Inventory

 

(40,488

)

17,379

 

Other current assets

 

79,511

 

(17,758

)

Accounts payable and accrued expenses

 

122,355

 

172,136

 

Net cash (used) by operating activities

 

(176,519

)

(1,126,548

)

Cash flows from investing activities:

 

 

 

 

 

Capital expenditures

 

 

(71,846

)

Net cash (used) by investing activities

 

 

(71,846

)

Cash flow from financing activities:

 

 

 

 

 

Proceeds from bridge loan financing

 

250,000

 

 

Repayments of bridge loan financing

 

(500,000

)

 

Issuance of common stock, net of offering costs

 

1,806,404

 

 

Net cash provided from financing activities

 

1,556,404

 

 

NET INCREASE (DECREASE) IN CASH

 

1,379,885

 

(1,198,394

)

CASH, BEGINNING OF THE PERIOD

 

76,147

 

2,805,021

 

CASH, END OF THE PERIOD

 

$

1,456,032

 

$

1,606,627

 

 

 

 

 

 

 

SUPPLEMENTAL CASH FLOW

 

 

 

 

 

Cash paid for interest

 

$

13,425

 

$

 

Stock issued for satisfaction of accrued compensation expense

 

$

540,000

 

$

 

Deferred offering costs applied against proceeds from offering

 

$

25,000

 

$

 

 

Forward-looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including prospects for XELR8’s distribution network. Actual results may differ from those discussed in such forward-looking statements. These forward-looking statements include risks and uncertainties that include the Company’s ability to attract and retain distributors; changes in demand for the Company’s products; changes in the level of operating expenses; changes in general economic conditions that impact consumer behavior and spending; product supply; the availability, amount, and cost of capital for the Company; and the Company’s use of such capital. More information about factors that potentially could affect the Company’s financial results is included in the Company’s filings with the Securities and Exchange Commission, including its Annual Report on Form 10-KSB for the year ended December 31, 2006 and all subsequent filings. Certain statements in this release regarding the Company’s agreements are in accordance with the guidelines established by the Federal Trade Commission for endorsements in advertising.

Company Contacts:

XELR8 Holdings, Inc.

Elite Financial Communications Group, LLC

 

John Pougnet, CEO/CFO

Dodi Handy, President and CEO

 

(303) 316-8577

(407) 585-1080

 

CEO@xelr8.com

bzi@efcg.net